NCT03775265 2026-04-13
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Janssen Research & Development, LLC
NRG Oncology
Janssen Research & Development, LLC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
University of Southampton